DXA remains the gold standard test for bone mineral density assessments. Hear more about how DXA scans work, who should get one and whether their use will become more widespread in clinical trials, akin to cardiac safety testing.

For more than 30 years, Philips Pharma Solutions, formerly BioTel Research, has been supporting clinical trials for pharma, biotech, and CROs for medical imaging and cardiac safety testing solutions.  

Industry leader Dr. Ed Ashton, VP of Oncology, at Philips Pharma Solutions, formerly BioTel Research, addresses the many different facets of oncology imaging techniques in clinical trials. 

Philips Pharma Solutions, formerly BioTel Research, offers global site, data, and project management for clinical trials in phases 1-4. We offer a wide range of imaging techniques and response criteria across a host of therapeutic areas.

The Philips Health band is a wrist-worn wearable device that captures clinically relevant, objective, and continuous cardiology, respiratory, sleep, and energy expenditure data. It provides intelligence for active evaluation of therapy support and future patient care.

Actigraphy Motion Biosensors wearable devices provide objective nocturnal scratching event measurement to evaluate the impact of a particular therapy or medication pertaining to Atopic Dermatitis.

In this article, read about perfusion imaging techniques and their use for clinical trials, with particular focus on perfusion imaging using DCE-MRI.

The Philips Health band (PHB) is a wrist-worn wearable device that leverages accelerometry and photoplethysmography (PPG) sensors to deliver sleep, cardiology, respiratory, and energy expenditure (EE) endpoints. In this study the resting heart rate (RHR) was evaluated for clinical relevance in adults with (or at risk) for life-style related chronic disease using the Philips Health band. RHR has been identified as a risk factor and a modifiable treatment outcome.

The Philips Health band (PHB) is a wrist-worn wearable device that leverages accelerometry and photoplethysmography (PPG) sensors to deliver sleep, cardiology, respiratory, and energy expenditure (EE) endpoints. In this study the respiration rate was evaluated for accuracy and performance in adults with (or at risk) for life-style related chronic disease using the Philips Health band.

The Philips Health band (PHB) is a wrist-worn wearable device that leverages accelerometry and photoplethysmography (PPG) sensors to deliver sleep, cardiology, respiratory, and energy expenditure (EE) endpoints. In this study, heart rate was evaluated for accuracy and performance in adults with (or at risk for) lifestyle-related chronic disease using the PHB in real time as well as for logged values.

Resting heart rate (RHR) may change with age and has been identified as both a risk factor and a modifiable treatment outcome, especially in lifestyle-related chronic disease. Monitoring RHR and prevention of long-term increases in RHR may aid to reduce the risks of adverse health outcomes.

This paper outlines the importance of measuring respiratory rate and explains how respiratory rate is assessed from photoplethysmography. New technology now enables a wrist-worn wearable device that measures and provides respiratory endpoints, including respiratory rate and resting respiratory rate.

Over the last several decades, several wearable HR monitoring devices have been developed with the intent of delivering automated, convenient, and continuous HR monitoring. A number of these technologies are wireless and based on photoplethysmography (PPG) signal assessment, which measure changes in blood volume in the microvascular tissue under the skin. Read more about the advantages of PPG and how it compares to ECG.

The Philips Health Band (PHB) is a wrist-worn activity and heart rate monitoring device. This study assessed the measurement performance of the PHB in adults at risk for lifestyle-related chronic disease such as cardiovascular disease and diabetes type 2 as well as adults with existing lifestyle-related chronic disease.

The relationship between PTSD and sleep disruption is complex. Sleep patterns of those with PTSD likely fluctuate over time depending on the chronicity of PTSD, nature of trauma, comorbid conditions, and medication usage. Actigraphy is thus ideally suited to studying these patterns as it is precise, non-invasive, objective, and provides continuous data over periods of weeks or months.

Activity patterns of those with multiple sclerosis (MS) fluctuate over time according to exacerbations and remissions, and therefore represent an important marker of disease progression. Read how actigraphy can be used to to measure conventional activity, sleep, and circadian endpoints and more to assist in studies.

Fibromyalgia (FM) is a neuropathic pain that affects millions of people in the United States. It, like most pain conditions, affects daily activity and sleep. The pain sensations are best measured by recording the patient’s own perceptions (patient-reported outcome) but the related effects of pain on activity and sleep can be measured objectively with actigraphy. Read how actigraphy provides useful insights into the activity patterns in patients with fibromyalgia.

Actigraphy is the measurement of motion used to monitor 24-hour activity patterns. Read how actigraphy was used in breast cancer studies to track sleep patterns, circadian endpoints as well as using datasets provided to investigate mathematical patterns which may be responsive to pharmacological therapy.

Alzheimer’s disease is a cognitive impairment, but it can manifest itself in many detrimental ways including alterations in daytime activity levels, sleep quality, and awake/sleep patterns. Read how actigraphy can provide important data when studying patients with Alzheimer's disease.

This poster demonstrates how the combination of high resolution actigraphy and advanced signal processing provides an accurate and non-invasive assessment of nocturnal scratching events.